Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity.

18F-BCPP-EF Dihydroethidium Microglia Mitochondrial complex I Quinolinic acid Reactive oxygen species

Journal

EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946

Informations de publication

Date de publication:
09 Oct 2021
Historique:
received: 27 04 2021
accepted: 17 09 2021
entrez: 10 10 2021
pubmed: 11 10 2021
medline: 11 10 2021
Statut: epublish

Résumé

Our study aimed to elucidate the intracellular processes associated with quinolinic acid (QA)-induced brain injury by acquiring semiquantitative fluorescent images of reactive oxygen species (ROS) generation and positron emission tomography (PET) images of mitochondrial complex I (MC-I) activity. Ex vivo fluorescent imaging with dihydroethidium (DHE) and PET scans with A strong DHE-derived fluorescent signal was detected in a focal area within the QA-injected striatum 3 h after QA injection, and increased fluorescent signal spread throughout the striatum and parts of the cerebral cortex after 24 h. By contrast, We successfully obtained functional images of focal ROS generation during the early period of excitotoxic injury, and microglial ROS generation and mitochondrial dysfunction were observed during the progression of the inflammatory response. Both ex vivo DHE imaging and in vivo

Identifiants

pubmed: 34628558
doi: 10.1186/s13550-021-00841-3
pii: 10.1186/s13550-021-00841-3
pmc: PMC8502189
doi:

Types de publication

Journal Article

Langues

eng

Pagination

99

Informations de copyright

© 2021. The Author(s).

Références

Science. 1983 Jan 21;219(4582):316-8
pubmed: 6849138
J Cereb Blood Flow Metab. 2014 Apr;34(4):708-14
pubmed: 24447952
J Histochem Cytochem. 1986 Sep;34(9):1109-15
pubmed: 2426339
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):755-63
pubmed: 24258008
Prog Neurobiol. 2005 Jun;76(2):77-98
pubmed: 16081203
Neurosci Res. 2006 Aug;55(4):397-402
pubmed: 16766071
Nat Rev Immunol. 2019 Aug;19(8):477-489
pubmed: 31036962
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
Neurochem Int. 2002 Jun;40(7):621-7
pubmed: 11900857
PLoS One. 2009;4(5):e5518
pubmed: 19436757
Neurochem Res. 2013 Aug;38(8):1553-60
pubmed: 23645222
Front Biosci. 2007 Jan 01;12:986-1007
pubmed: 17127354
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18769-70
pubmed: 16365283
Mol Neurobiol. 2016 Mar;53(2):1181-1194
pubmed: 25598354
Free Radic Biol Med. 2009 Aug 15;47(4):333-43
pubmed: 19427899
Chem Biol Interact. 1999 Apr 15;118(3):201-15
pubmed: 10362227
Neurosci Lett. 2010 Jan 18;469(1):39-43
pubmed: 19945511
Mol Imaging. 2019 Jan-Dec;18:1536012118820421
pubmed: 30799681
Lancet Neurol. 2009 Apr;8(4):382-97
pubmed: 19296921
J Neurochem. 2006 Dec;99(6):1531-42
pubmed: 17230642
J Nucl Med. 2014 Mar;55(3):473-80
pubmed: 24470629
Biochem Soc Trans. 2007 Nov;35(Pt 5):1127-32
pubmed: 17956294
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2127-36
pubmed: 24919653
Neuropharmacology. 1983 Dec;22(12A):1331-42
pubmed: 6229703
J Cereb Blood Flow Metab. 2004 Feb;24(2):188-90
pubmed: 14747745
Neurotox Res. 2012 Nov;22(4):251-64
pubmed: 22488161
Eur J Pharmacol. 1981 Jul 10;72(4):411-2
pubmed: 6268428
Synapse. 2003 Aug;49(2):134-41
pubmed: 12740869
J Nucl Med. 2020 Jan;61(1):96-103
pubmed: 31324712
J Biol Chem. 2004 Jan 9;279(2):1415-21
pubmed: 14578353
Oxid Med Cell Longev. 2013;2013:264935
pubmed: 23533686
Neuroreport. 2001 Aug 28;12(12):2693-6
pubmed: 11522949
Nature. 1986 May 8-14;321(6066):168-71
pubmed: 2422561
Neurosci Lett. 1993 Sep 3;159(1-2):51-4
pubmed: 8264978
Neuroscience. 2004;127(2):319-32
pubmed: 15262322
Org Biomol Chem. 2020 Apr 1;18(13):2387-2391
pubmed: 32073113
J Nucl Med. 1994 Jan;35(1):104-12
pubmed: 8271030
Synapse. 2003 Nov;50(2):137-43
pubmed: 12923816
J Neurosci. 1996 Feb 15;16(4):1324-36
pubmed: 8778284
Neuroreport. 2000 Feb 7;11(2):249-53
pubmed: 10674464
J Nucl Med. 2006 Apr;47(4):679-88
pubmed: 16595503
Pharmacol Rev. 1993 Sep;45(3):309-79
pubmed: 8248282
Science. 2007 Dec 7;318(5856):1645-7
pubmed: 18063801
Neurology. 2020 Apr 14;94(15):e1592-e1604
pubmed: 32139504
J Cereb Blood Flow Metab. 2012 Jan;32(1):23-32
pubmed: 21847136
Exp Cell Res. 2016 Jan 15;340(2):315-26
pubmed: 26511505
Exp Gerontol. 2010 Aug;45(7-8):466-72
pubmed: 20064600
Sci Rep. 2016 Jul 21;6:30127
pubmed: 27440054
J Neurochem. 1997 Oct;69(4):1629-39
pubmed: 9326292
Free Radic Biol Med. 2008 Sep 1;45(5):686-99
pubmed: 18590811
Mol Neurodegener. 2009 Dec 31;4:55
pubmed: 20042120
J Biol Chem. 2003 Sep 19;278(38):36027-31
pubmed: 12840017
Neuroscientist. 2002 Aug;8(4):323-34
pubmed: 12194501
Neurosci Lett. 1983 Jul 15;38(1):85-90
pubmed: 6225037
Brain Res. 2005 Mar 28;1039(1-2):199-202
pubmed: 15781062
Nature. 2011 Jan 13;469(7329):221-5
pubmed: 21124315
Mol Neurobiol. 2003 Dec;28(3):229-44
pubmed: 14709787
Oxid Med Cell Longev. 2013;2013:963520
pubmed: 24381719
Neuroscience. 2007 Jun 8;146(4):1704-18
pubmed: 17459592

Auteurs

Rie Hosoi (R)

Division of Health Sciences, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka, 565-0871, Japan. hosoi@sahs.med.osaka-u.ac.jp.

Yuka Fujii (Y)

Division of Health Sciences, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Ohba Hiroyuki (O)

Central Research Laboratory, Hamamatsu Photonics K. K, 5000 Hirakuchi, Hamakita, Hamamatsu, Shizuoka, 434-8601, Japan.

Miho Shukuri (M)

Laboratory of Physical Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo, 194-8543, Japan.

Shingo Nishiyama (S)

Central Research Laboratory, Hamamatsu Photonics K. K, 5000 Hirakuchi, Hamakita, Hamamatsu, Shizuoka, 434-8601, Japan.

Masakatsu Kanazawa (M)

Central Research Laboratory, Hamamatsu Photonics K. K, 5000 Hirakuchi, Hamakita, Hamamatsu, Shizuoka, 434-8601, Japan.

Kenichiro Todoroki (K)

Department of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8526, Japan.

Yasushi Arano (Y)

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8675, Japan.

Toshihiro Sakai (T)

Hanwa Intelligent Medical Center, Hanwa Daini Senboku Hospital, 3176 Fukaikitamachi, Naka-ku, Sakai, Osaka, 599-8271, Japan.

Hideo Tsukada (H)

Central Research Laboratory, Hamamatsu Photonics K. K, 5000 Hirakuchi, Hamakita, Hamamatsu, Shizuoka, 434-8601, Japan.

Osamu Inoue (O)

Hanwa Intelligent Medical Center, Hanwa Daini Senboku Hospital, 3176 Fukaikitamachi, Naka-ku, Sakai, Osaka, 599-8271, Japan.

Classifications MeSH